Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal decision profile

Folia Biologica

Immunology and Microbiology · Biochemistry, Genetics and Molecular Biology

First Faculty of Medicine, Charles UniversityCzech RepublicpISSN 0015-5500eISSN 0015-5500

Journal Metrics Score

Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.

2026

1.2

Journal Metrics Score 2026 · 2021–2024 window citedness 0.85.

Submission-to-acceptance

Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.

PUBMED

Not available — there are not enough recent PubMed records with both received and accepted dates.

Indicative APC

Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.

OPENALEX · VERIFY

Not available

No journal-level APC is available in the current OpenAlex snapshot. Cost is excluded from scoring.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible

Metrics Score

Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.

1.22026 · OPENALEX

Source output rank

Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.

#447 / 1,480LIFETIME OUTPUT

Highly cited papers

Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.

2.1%FIELD-NORMALIZED TOP 10%

Field-normalized impact

Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.

0.28MEDIAN FWCI

Submission-to-acceptance

Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.

—NOT AVAILABLE

Recent output

Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.

24 / yr2021–2024 AVG

Field-normalized top 10% share2.1%

2 of 96 works · same type, year & subfield

Field-normalized top 1% share0%

0 works · same type, year & subfield

Median FWCI0.28×

Below field-year expectation

Source output rank#447

of 1,480 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.28, so its typical recent paper runs about 72% below its field benchmark.

What does Top 10% Share mean?

2.1% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

332016

312017

252018

292019

262020

262021

222022

252023

232024

262025

Recent work-type mix

96 OpenAlex works · 2021–2024

Article97.9%

Erratum2.1%

OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.

Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

MicroRNAsLung NeoplasmsCarcinoma, Non-Small-Cell LungCell ProliferationApoptosisBreast NeoplasmsRNA, Long Noncoding

Leading OpenAlex topics

2021–2024 works

Cancer-related molecular mechanisms research3

Cancer, Hypoxia, and Metabolism3

Liver Disease Diagnosis and Treatment3

Bone Tumor Diagnosis and Treatments2

Cancer Immunotherapy and Biomarkers2

Epigenetics and DNA Methylation2

Erythrocyte Function and Pathophysiology2

Extracellular vesicles in disease2

Liver physiology and pathology2

MicroRNA in disease regulation2

Methodology: OpenAlex snapshot 2026-08-12. FWCI, percentile badges, topics, and type mix use 96 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Recommended alternatives

Candidates share the leading OpenAlex topic, then subfield or field when needed, and are ranked by current Journal Metrics Score.

OpenAlex topic-neighbor model · Preview

Cancer Immunology ImmunotherapyTopic-neighbor alternative5.3Metrics Score93dIQR 64–135dSubmission → acceptance$$$Cost*Expert Review of VaccinesTopic-neighbor alternative5.2Metrics Score—Submission → acceptance$—Cost*International Journal of CancerTopic-neighbor alternative4.1Metrics Score156dIQR 118–198dSubmission → acceptance$$$Cost*Expert Opinion On Biological TherapyTopic-neighbor alternative3.3Metrics Score—Submission → acceptance$—Cost*Immunotherapy AdvancesTopic-neighbor alternative2.9Metrics Score—Submission → acceptance$$Cost*Journal of ImmunotherapyTopic-neighbor alternative2.1Metrics Score—Submission → acceptance$—Cost*

More alternative journals

Annual Review of Immunology Immunity Nature Reviews Immunology Cellular & Molecular Immunology Science Immunology Seminars in Immunopathology

* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
Category	Quartile
Immunology	Q4
Cancer Research	Q4
Molecular Biology	Q4
Genetics	Q3

Considering submitting to Folia Biologica?

Use your manuscript title to find AI-ranked journals with related recent work, fit reasons, risks, and submission strategy.

Match my manuscript →

Subfield Quartile

CAS Block

Ranking and source check

#2,612

of 3,739 Biology & Basic Science field journals

#270

among Q3 Biology & Basic Science journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

View all Biology & Basic Science journals →View Q1 Biology & Basic Science journals →

Journal Details

OpenAlex Works

856

H-Index

Fully Open Access

Recent OA Works

856

Subject Areas

ImmunologyCancer ResearchMolecular BiologyGenetics

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

Related Guides

Field Rankings

Best Oncology Journals: Journal Metrics Scores and Cancer Research Guide

12 min read

Field Rankings

Archived Biology Journal Selection Guide

14 min read

Field Rankings

Archived Chemistry Journal Selection Guide

14 min read

Publishing Guide

How to Choose the Right Journal for Your Research Paper

15 min read

Back to Search